×
About 2,290 results

ALLMedicine™ Hypopituitarism Center

Research & Reviews  824 results

The Curious Case of Hypopituitarism.
https://doi.org/10.1093/jnen/nlac046
Journal of Neuropathology and Experimental Neurology; Newell C, Kline GA et. al.

Jun 26th, 2022 - The Curious Case of Hypopituitarism.|2022|Newell C,Kline GA,Joseph JT,|

Unusual manifestations of adrenal insufficiency: A case report of hypopituitarism and W...
https://doi.org/10.1097/MD.0000000000029274
Medicine Hsu CC, Lin HD et. al.

Jun 7th, 2022 - Pituitary apoplexy occurs in about 8% of those with nonfunctioning pituitary adenoma. Subsequent hormone deficiency, especially corticotropic deficiency, is the most common finding. We describe the unusual manifestations of adrenal insufficiency t...

Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
https://clinicaltrials.gov/ct2/show/NCT05403255

Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...

IgG4-related disease presenting with multiorgan involvement.
https://doi.org/10.1136/bcr-2022-250637
BMJ Case Reports; Tellez R, Bromfield B et. al.

Jun 2nd, 2022 - Immunoglobulin G4-related disease (IgG4-RD) is a rare fibroinflammatory immune-mediated condition which can affect multiple organ systems and form mass-like lesions. Initial presentation can mimic other diseases such as pancreatic malignancy when ...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practi...
https://doi.org/10.1210/jc.2016-2118
The Journal of Clinical Endocrinology and Metabolism; Fleseriu M, Hashim IA et. al.

Nov 5th, 2016 - To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pri...
https://doi.org/10.1227/NEU.0000000000001389
Neurosurgery Lucas JW, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present clinically with vision loss and hypopituitarism. To characterize the existing literature as it pertains to the initial management of NFPAs. A sys...

Pituitary incidentaloma: an endocrine society clinical practice guideline.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422
The Journal of Clinical Endocrinology and Metabolism; Freda PU, Beckers AM et. al.

Apr 9th, 2011 - The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-per...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  32 results

Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
https://clinicaltrials.gov/ct2/show/NCT05403255

Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...

Treatment of Adrenal Insufficiency in Children
https://clinicaltrials.gov/ct2/show/NCT02720952

May 4th, 2022 - This is a Phase 3, open label, single centre study of Infacort® in neonates, infants and children less than 6 years of age with adrenal insufficiency. The study will be conducted in a total of 24 subjects, before their 6th birthday, requiring repl...

Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
https://clinicaltrials.gov/ct2/show/NCT04648137

Apr 13th, 2022 - Disruption of the hypothalamic-pituitary axis due to congenital abnormalities, tumors or head trauma may cause anterior and/or posterior pituitary deficiency also known as partial or panhypopituitarism. Patients with hypopituitarism, especially th...

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
https://clinicaltrials.gov/ct2/show/NCT05319301

Apr 8th, 2022 - Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior and sexual function. Hypopituitarism is associated wi...

Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
https://clinicaltrials.gov/ct2/show/NCT05206149

Jan 25th, 2022 - The diagnosis of secondary hypoadrenalism and GH deficiency (GHD) often requires the performance of a dynamic test. The glucagon stimulation test (GST) is one of the options for evaluating hypothalamic-pituitary function, representing a stimulus f...

see more →

News  49 results

Multidisciplinary Care for Malignant Melanoma
https://www.onclive.com/view/multidisciplinary-care-for-malignant-melanoma

Apr 2nd, 2021 - For High-Definition, Click The treatment of patients with metastatic melanoma requires a team approach. The complexities of this disease warrants impute from several specialists to properly deliver care, the panelists agree. Along these lines, h...

I/O Second-Line Treatment
https://www.onclive.com/view/i-o-second-line-treatment

Apr 2nd, 2021 - Peter Galle, MD: What do we have as evidence? The only I/O agent that has been convincing in demonstrating benefit was atezolizumab in combination with bevacizumab in first line. That’s what we have. The monotherapy has not made it into a signific...

FDA Approves Two New Indications for Pembrolizumab in Advanced Melanoma
https://www.onclive.com/view/fda-approves-two-new-indications-for-pembrolizumab-in-advanced-melanoma

Dec 4th, 2020 - Roger M. Perlmutter, MD, PhD The FDA has expanded the approval for single-agent pembrolizumab (Keytruda) to include the frontline treatment of patients with advanced melanoma regardless of BRAF status, based on a substantial improvement in progre...

Fast Five Quiz: Test Your Knowledge of Acromegaly
https://reference.medscape.com/viewarticle/875763_6

Sep 16th, 2020 - Answer 5/5 Which of the following is accurate regarding treatment of acromegaly? Your peers chose: Pharmacologic therapy is the first-line treatment for acromegaly 0% Radiation therapy is routinely indicated for most patients with acromegaly 0% Fo...

Guidance for Endocrinologists During COVID-19 Pandemic
https://www.medpagetoday.com/endocrinology/generalendocrinology/85879

Apr 9th, 2020 - In response to the COVID-19 pandemic, endocrinologists should take certain precautions with patients they commonly treat, according to new guidance from editors of The Journal of Clinical Endocrinology & Metabolism. Editor-in-Chief Paul Stewart, M...

see more →

Patient Education  5 results see all →